PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-21.42%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-28.98%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-57.88%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-57.88%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
50.49%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
50.61%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
50.48%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.27%
Slight or no buybacks while CVE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
2.35%
Maintaining or increasing dividends while CVE cut them. John Neff might see a strong edge in shareholder returns.
-1.10%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
940.00%
Positive FCF growth while CVE is negative. John Neff would see a strong competitive edge in net cash generation.
-63.78%
Negative 10Y revenue/share CAGR while CVE stands at 38.84%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-37.08%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-43.90%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-84.61%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-57.43%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-45.43%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-130.43%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-1172.56%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-568.09%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-54.65%
Negative equity/share CAGR over 10 years while CVE stands at 16.93%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-68.92%
Negative 5Y equity/share growth while CVE is at 12.33%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
1.71%
Below 50% of CVE's 15.31%. Michael Burry suspects a serious short-term disadvantage in building book value.
-28.47%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-76.83%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-76.83%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
37.45%
AR growth well above CVE's 1.71%. Michael Burry fears inflated revenue or higher default risk in the near future.
-26.47%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-9.54%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-8.46%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-10.00%
We’re deleveraging while CVE stands at 3.37%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-7.63%
We cut SG&A while CVE invests at 45.33%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.